Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases - Contacts and Locations

Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases

This study is currently recruiting participants.

Study NCT00041158. Last updated on November 1, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00041158

Locations


United States, Maryland
	NCI - Center for Cancer Research-Medical Oncology	Recruiting
	Bethesda, Maryland, United States, 20892
	Contact: Tricia Kunst, RN 301-451-1233 tricia_kunst@nih.gov
	Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office	Recruiting
	Bethesda, Maryland, United States, 20892-1182
	Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937

Sponsors and Collaborators

NCI - Center for Cancer Research-Medical Oncology

National Cancer Institute (NCI)

Investigators


Study Chair:	David S. Schrump, MD	NCI - Surgery Branch